Pitcairn Wealth Advisors LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 2089089 CONSHOHOCKEN, PA

Position in AXSM

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$752,422

-$374,265 QoQ

Shares Held

3,074

-53.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#287

of 503 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pitcairn Wealth Advisors LLC holds $1,686,644 across 3 Biotechnology names. AXSM ranks #1 (44.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc. This page	3,074	$752,422
2	REGN	Regeneron Pharmaceuticals, Inc.	1,057	$659,081
3	ALNY	Alnylam Pharmaceuticals, Inc.	914	$275,141

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$752,422	3,074	-53.9%	Shares	Sole	2026-08-10
2026-03-31	$1,126,687	6,666	+0.4%	Shares	Sole	2026-05-13
2025-12-31	$1,212,546	6,639	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.